MX2022002288A - Administracion de cannabinoides no inmunogenicos biorremediadores. - Google Patents

Administracion de cannabinoides no inmunogenicos biorremediadores.

Info

Publication number
MX2022002288A
MX2022002288A MX2022002288A MX2022002288A MX2022002288A MX 2022002288 A MX2022002288 A MX 2022002288A MX 2022002288 A MX2022002288 A MX 2022002288A MX 2022002288 A MX2022002288 A MX 2022002288A MX 2022002288 A MX2022002288 A MX 2022002288A
Authority
MX
Mexico
Prior art keywords
remedial
immunogenic
bio
cannabinoid delivery
monomer
Prior art date
Application number
MX2022002288A
Other languages
English (en)
Inventor
Michael Flemmens
Original Assignee
Sorse Tech Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sorse Tech Corporation filed Critical Sorse Tech Corporation
Publication of MX2022002288A publication Critical patent/MX2022002288A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/60—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from the reaction of a mixture of hydroxy carboxylic acids, polycarboxylic acids and polyhydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/12—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from polycarboxylic acids and polyhydroxy compounds
    • C08G63/123—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from polycarboxylic acids and polyhydroxy compounds the acids or hydroxy compounds containing carbocyclic rings
    • C08G63/133—Hydroxy compounds containing aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se proporciona un método (10) para fabricar un mecanismo de administración de cannabinoides no inmunogénicos biorremediadores. Se combinan un monómero de alcohol y un monómero de ácido (11). Se añaden uno o más cannabinoides (12) a la combinación de monómero de alcohol y monómero de ácido. Un material polimérico de cannabinoides, monómero de alcohol y monómero de ácido (15) se forma y se procesa para convertirse en un producto para inserción, inyección o aplicación tópica por parte de un usuario.
MX2022002288A 2019-08-23 2020-08-24 Administracion de cannabinoides no inmunogenicos biorremediadores. MX2022002288A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962891179P 2019-08-23 2019-08-23
PCT/US2020/047673 WO2021041335A1 (en) 2019-08-23 2020-08-24 Bio-remedial non-immunogenic cannabinoid delivery
US17/001,250 US20210052494A1 (en) 2019-08-23 2020-08-24 Bio-remedial non-immunogenic cannabinoid delivery

Publications (1)

Publication Number Publication Date
MX2022002288A true MX2022002288A (es) 2022-06-08

Family

ID=74645627

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022002288A MX2022002288A (es) 2019-08-23 2020-08-24 Administracion de cannabinoides no inmunogenicos biorremediadores.

Country Status (5)

Country Link
US (1) US20210052494A1 (es)
CO (1) CO2022001865A2 (es)
CR (1) CR20220081A (es)
MX (1) MX2022002288A (es)
WO (1) WO2021041335A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210322365A1 (en) * 2020-04-17 2021-10-21 University Of Connecticut Polycannabinoids, compounds, compositions and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3149067B1 (en) 2014-05-30 2021-03-17 The Secant Group, LLC Water-mediated preparations of polymeric materials
CA2995418A1 (en) * 2015-08-11 2017-02-16 KannaInnovations LLC Topical compositions comprising hydroxy acids and cannabinoids for skin care
US20180263954A1 (en) * 2016-09-27 2018-09-20 CannTab Therapeutics, Limited Sustained Release Cannabinoid Formulations
CA3056286A1 (en) * 2017-03-16 2018-09-20 CannTab Therapeutics Limited Modified release multi-layer tablet cannabinoid formulations
IL271890B2 (en) * 2017-07-11 2023-11-01 Secant Group Llc Interleukin-inhibiting poly(glycerol subcategory) copolymers and methods for their preparation and use
US10918724B2 (en) * 2018-02-21 2021-02-16 The Secant Group, Llc Dermocosmetic compositions including glycerol-sebacate

Also Published As

Publication number Publication date
CR20220081A (es) 2022-07-14
US20210052494A1 (en) 2021-02-25
WO2021041335A1 (en) 2021-03-04
CO2022001865A2 (es) 2022-07-08

Similar Documents

Publication Publication Date Title
MX2019001552A (es) Composicion curable fotocromatica, uso de la misma y monomeros de polirotaxano.
CO2021005364A2 (es) Un proceso para elaborar un producto análogo de carne
AU2019268099A1 (en) Adhesive compositions comprising type-ii cellulose
BR112017027813A2 (pt) conjugados de agente de ligação-droga (adcs) e conjugados de agente de ligação-pró-droga (apdcs) tendo grupos enzimaticamente cliváveis
SG10201808743VA (en) Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa
BR112018000399A2 (pt) método para preparar um produto polimérico, produto polimérico, produto polimérico para cultivar células ou tecidos e solução de revestimento polimérico
MX2022002288A (es) Administracion de cannabinoides no inmunogenicos biorremediadores.
NZ763651A (en) Aerosolisable formulation
MX2019000902A (es) Desinfectantes topicos emolientes.
CR10569A (es) Una nueva composicion antifungica
MX2021005476A (es) Plantas de cannabis con un perfil de cannabinoides enriquecidas con ¿-9-tetrahidrocannabinol y cannabigerol.
WO2021262672A8 (en) Sars-cov-2 rbd constructs
UA98180C2 (ru) Кислотный полисахарид, способы его получения, местная композиция и ее применение
BR112021026245A2 (pt) Método de extração.
CY1110662T1 (el) Απαλλαγμενοι απο πηκτωματα βλαστοι λιναριου και το παραπροϊον τους, καθως και η παραγωγη και η εφαρμογη τους
WO2021118318A3 (ko) 신규한 인돌 유도체 및 이의 용도
WO2019078653A3 (ko) 변성 공액디엔계 중합체 및 이의 제조방법
WO2020051047A3 (en) Cannabinoid and anesthetic compositions and methods
WO2018194327A3 (ko) 해양 유래 신규 미생물 및 이를 이용한 화장품 조성물
MY189198A (en) Polycarbodiimide composition, method for producing a polycarbodiimide composition, water-dispersed composition, solution composition, resin composition, and cured resin
WO2022207945A3 (en) "novel photoinitiators"
MX2022004160A (es) Composicion de poliuretano de dos componentes.
MX2020008941A (es) Composicion precursora para compuestos termoplasticos acrilicos y su metodo de preparacion y uso.
WO2023114932A3 (en) Subtilisin variants and uses thereof
ATE502643T1 (de) Natürliche zusammensetzung